12:48 | 21st March 2019

World News:

Thu 29 Mar, 2012
By Editor

Latest Headlines

Youth Invited to Design Social Media Strategy for UNAIDS

The United Nations has invited young people to create and shape the new UN strategy on youth and HIV/AIDS through an online collaborative project launched Tuesday, according to an article on the UN website

Blood donation center rejects straight man because he 'appeared' gay

A 22-year-old straight man was refused the right to donating blood after staff at a blood bank believed the man ‘seemed’ gay.

Nicki Minaj and Ricky Martin new faces of MAC Viva Glam HIV/AIDS campaign

Nicki Minaj and Ricky Martin have been announced as the faces of the 2012 MAC Viva Glam campaign to fight HIV/AIDS.

UNAIDS and WHO hail new results for Once - daily pill for HIV Negative people

New data from studies in Kenya, Uganda and Botswana confirm major role of antiretroviral medicine in preventing heterosexual HIV transmission

New US treatment guidelines reccomend antiretrovirals for all with HIV

Newly updated US antiretroviral treatment guidelines are recommending antiretroviral treatment for all people with HIV infection, with particular emphasis on treatment for: people with CD4 cell counts below 500; anyone at risk of transmitting HIV to partners; pregnant women; and people with hepatitis B co-infection or HIV-related kidney disease.

The new recommendations strengthen previous US recommendations on when to start treatment, which recommended initiating treatment at CD4 cell counts between 350 and 500 cells/mm3. The 2009 guidelines panel was, however, divided as to the strength of this recommendation: based on available evidence, 55% of the panel considered it a 'strong' recommendation and 45% 'moderate'. The 2009 guidelines panel also noted that it was split on whether to recommend treatment at CD4 counts above 500.

The new Department of Health and Human Services (DHHS) guidelines state that panel members were evenly divided between recommending therapy at CD4 counts above 500 and considering it optional, but this caveat is presented within an overall framework that now states “antiretroviral therapy is recommended for all HIV-infected individuals”.

In support of this recommendation, the new guidelines cite a range of evidence showing associations between viral replication and increased risk of illness and death in people with HIV, but do not discuss the absolute reduction in risk that might be associated with earlier treatment, nor the number of people who would need to receive treatment in order to prevent one new death or event in a year.

To read more on this subject visit : www.http://www.aidsmap.com/page/2295568/

Source: www.nam.org.uk


Back to previous page